Marker Therapeutics, Inc. (MRKR): EPS (Diluted)
-$0.79
Year ended 2025-12-31
| Period ended | EPS (Diluted) | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$0.79 | n/m | 2026-03-18, From 2025-01-01 |
| 2024-12-31 | -$1.19 | n/m | 2026-03-18, From 2024-01-01 |
| 2023-12-31 | -$0.94 | n/m | 2025-03-31, From 2023-01-01 |
| 2022-12-31 | -$3.58 | n/m | 2024-03-26, From 2022-01-01 |
| 2021-12-31 | -$5.47 | n/c | 2023-03-22, From 2021-01-01 |
| 2020-12-31 | -$0.61 | n/a | 2022-03-17, From 2020-01-01 |
| No annual figure between 2017-12-31 and 2020-12-31. | |||
| 2017-12-31 | -$1.16 | n/m | 2018-03-23, From 2017-01-01 |
| 2016-12-31 | -$0.72 | n/m | 2018-03-23, From 2016-01-01 |
| 2015-12-31 | -$9.30 | n/a | 2017-03-14, From 2015-01-01 |
EPS (Diluted) at similar companies
| Company | Year ended | EPS (Diluted) | Change YoY |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | 2025-12-31 | -$0.79 | n/m |
| Camp4 Therapeutics Corp (CAMP) | 2025-12-31 | -$2.65 | n/m |
| China Pharma Holdings, Inc. (CPHI) | 2025-12-31 | -$0.74 | n/m |
| TherapeuticsMD, Inc. (TXMD) | 2025-12-31 | -$0.05 | n/m |
| Xenetic Biosciences, Inc. (XBIO) | 2025-12-31 | -$1.58 | n/m |
| ProPhase Labs, Inc. (PRPH) | 2025-12-31 | -$1.74 | n/m |
| Upstream Bio, Inc. (UPB) | 2025-12-31 | -$2.66 | n/m |
| Cartesian Therapeutics, Inc. (RNAC) | 2025-12-31 | -$5.02 | n/m |
| Ensysce Biosciences, Inc. (ENSC) | 2025-12-31 | -$3.98 | n/m |
Compare MRKR, CAMP, CPHI, TXMD side by side · Screen every company in Pharmaceutical Preparations ↗